CENTENE FOUNDATION AND THE LITTLE BIT FOUNDATION PARTNER WITH ST. LOUIS CITY SC AND THE PRO FOOTBALL HALL OF FAME TO ENHANCE HEALTH AND WELLNESS OF ST. LOUIS STUDENTS
Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC) focused on investing in initiatives with holistic approaches to dismantling barriers to health, and The Little Bit Foundation (“Little Bit”), an organization that works to eliminate barriers to learning for under-resourced students in the St. Louis region, today announced…
Cardinal Health and Children’s Hospital Association Announce Second Preventing Youth Suicide Cohort
Cardinal Health (NYSE: CAH) in partnership with Children’s Hospitals Association (CHA) and the Zero Suicide Institute (ZSI) announced today the second round of grant recipients for the Preventing Youth Suicide: A Cardinal Health Foundation National Collaborative. The grants, which total…
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adults with Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of KEYTRUDA, Merck’s anti-PD-1 therapy, for…
AbbVie Calls on Public to Vote for the 2023 AbbVie Cystic Fibrosis Scholarship “Thriving Students”
AbbVie today announced the start of its two-week public voting period for the 2023 Thriving Undergraduate and Graduate Scholarships. Following this voting period, scholarships totaling $25,000 each will be awarded to two commendable students living with cystic fibrosis (CF), an inherited chronic…
Novartis shareholders approve the proposed 100% Spin-off of Sandoz
At an Extraordinary General Meeting held today, Novartis shareholders approved the proposed 100% Spin-off of Sandoz, the Generics and Biosimilars business of Novartis. Shareholders also approved an ordinary capital decrease of the share capital of Novartis AG in the amount…
Henry Schein Medical and North American Rescue to Exhibit at EMS World Expo
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), and North American Recue, a Henry Schein Medical business, today announced their presence at the EMS World Expo. From September 18 through September 22 in New Orleans,…
Florida Dialysis Centers Market Size, Share & Trends Analysis Report 2023: A $1.3 Billion Market by 2030 – Escalating Demand for Dialysis Units Propelling Growth – ResearchAndMarkets.com
The “Florida Dialysis Centers Market Size, Share & Trends Analysis Report By Modality (In-Center, In-Home, SNF-based), By Dialysis Type (Hemodialysis, Peritoneal Dialysis), By Facility Type, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The Florida dialysis centers market size…
Precision Fermentation Fuels Growth in Ophthalmic Viscoelastic Devices Market: Opportunities and Key Segments – ResearchAndMarkets.com
The “Ophthalmic Viscoelastic Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033“ report has been added to ResearchAndMarkets.com’s offering. This report provides a comprehensive analysis of the Ophthalmic Viscoelastic Devices (OVD)…
Emulate Publishes Novel Framework to Pave the Way for the Integration of Liver-Chip Technology into Pharmaceutical Safety Assessment
Emulate, Inc., the leading provider of next-generation in vitro models, today announced the publication “Integrating Liver-Chip Data into Pharmaceutical Decision-Making Processes” in Expert Opinion on Drug Discovery. The article introduces a decision-making framework that includes two guidelines for researchers to use in…
Global Cell Freezing Media Market to Reach $291.3 Million by 2030 – Driven by Rising Adoption of Ready-to-Use Freezing Media – ResearchAndMarkets.com
The “Cell Freezing Media Market Size, Share & Trends Analysis Report By Product (DMSO, Glycerol), By Application (Stem Cell Lines, Cancer Cell Lines), By End-use, By Region, And Segment Forecasts, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. This report projects that the global…
Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anemia
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythemia vera and post-essential thrombocythemia), in adults with anemia. Ojjaara is a…
Nilogen Oncosystems announces new Chief Scientific Officer
Nilogen Oncosystems, a privately-held biotechnology company dedicated to increasing efficiency and reducing risk in the oncology drug development process, has announced the appointment of its Vice President of Research and Operations, Rikhia Chakraborty, Ph.D., to Chief Scientific Officer. As Chief…